Erika Iervasi

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Tyrosine Kinase

Prostate Cancer

Top Venues

International journal of molecular sciences

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Matteo Lusardi, Maria Grazia Signorello, Eleonora Russo, Debora Caviglia, Marco Ponassi, Erika Iervasi, Camillo Rosano, Chiara Brullo, Andrea Spallarossa
Structure-Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents. International journal of molecular sciences 25 (9) (2024)
Matteo Lusardi, Maria Grazia Signorello, Eleonora Russo, Debora Caviglia, Marco Ponassi, Erika Iervasi, Camillo Rosano, Chiara Brullo, Andrea Spallarossa
Structure-Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents. International journal of molecular sciences 25 (9) (2024)
Ashleigh Williams, Emma Cooper, Bethany Clark, Laura Perry, Marco Ponassi, Erika Iervasi, Chiara Brullo, Alexander Greenhough, Michael Ladomery
Anticancer Effects of the Novel Pyrazolyl-Urea GeGe-3. International journal of molecular sciences 25 (10) (2024)
Erika Iervasi, Gabriela Coronel Vargas, Tiziana Bachetti, Kateryna Tkachenko, Andrea Spallarossa, Chiara Brullo, Camillo Rosano, Sonia Carta, Paola Barboro, Aldo Profumo, Marco Ponassi
A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo-Pyrazole Treatment in SKMEL-28 Melanoma Cells. International journal of molecular sciences 25 (12) (2024)
Ashleigh Williams, Emma Cooper, Bethany Clark, Laura Perry, Marco Ponassi, Erika Iervasi, Chiara Brullo, Alexander Greenhough, Michael Ladomery
Anticancer Effects of the Novel Pyrazolyl-Urea GeGe-3. International journal of molecular sciences 25 (10) (2024)
Erika Iervasi, Gabriela Coronel Vargas, Tiziana Bachetti, Kateryna Tkachenko, Andrea Spallarossa, Chiara Brullo, Camillo Rosano, Sonia Carta, Paola Barboro, Aldo Profumo, Marco Ponassi
A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo-Pyrazole Treatment in SKMEL-28 Melanoma Cells. International journal of molecular sciences 25 (12) (2024)
Erika Iervasi, Gabriela Coronel Vargas, Tiziana Bachetti, Kateryna Tkachenko, Andrea Spallarossa, Chiara Brullo, Camillo Rosano, Sonia Carta, Paola Barboro, Aldo Profumo, Marco Ponassi
A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo-Pyrazole Treatment in SKMEL-28 Melanoma Cells. International journal of molecular sciences 25 (12) (2024)
Katia Cortese, Marco Ponassi, Aldo Profumo, Gabriela Coronel Vargas, Erika Iervasi, Maria Cristina Gagliani, Grazia Bellese, Sara Tavella, Patrizio Castagnola
Lipid Metabolism Reprogramming and Trastuzumab Resistance in Breast Cancer Cell Lines Overexpressing the ERBB2 Membrane Receptor. Membranes 13 (6) (2023)
Katia Cortese, Marco Ponassi, Aldo Profumo, Gabriela Coronel Vargas, Erika Iervasi, Maria Cristina Gagliani, Grazia Bellese, Sara Tavella, Patrizio Castagnola
Lipid Metabolism Reprogramming and Trastuzumab Resistance in Breast Cancer Cell Lines Overexpressing the ERBB2 Membrane Receptor. Membranes 13 (6) (2023)
Katia Cortese, Marco Ponassi, Aldo Profumo, Gabriela Coronel Vargas, Erika Iervasi, Maria Cristina Gagliani, Grazia Bellese, Sara Tavella, Patrizio Castagnola
Lipid Metabolism Reprogramming and Trastuzumab Resistance in Breast Cancer Cell Lines Overexpressing the ERBB2 Membrane Receptor. Membranes 13 (6) (2023)
Imene Ben Toumia, Marco Ponassi, Paola Barboro, Erika Iervasi, Gabriela Coronel Vargas, Barbara Banelli, Stefano Fiordoro, Leila Chekir Ghedira, Franz Heinrich Kohnke, Alberto Izzotti, Camillo Rosano
Two calix[4]pyrroles as potential therapeutics for castration-resistant prostate cancer. Investigational new drugs 40 (6) (2022)